This inventor holds 1 USPTO granted patent. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yong Quan - Innovator in Antibody Formulations
Introduction
Yong Quan is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of antibody formulations. His work focuses on innovative solutions for treating various disorders, including cancer.
Latest Patents
Yong Quan holds a patent for B7-H4 antibody formulations. This patent provides pharmaceutical compositions that comprise antibodies and antigen-binding fragments specifically designed to bind to human B7-H4. Additionally, the patent outlines methods for treating disorders, such as cancer, by administering these pharmaceutical compositions.
Career Highlights
Yong Quan is currently associated with Five Prime Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in antibody formulations has positioned him as a key player in the biotechnology sector.
Collaborations
Yong has collaborated with several professionals in his field, including Chin-Yi Huang and Harjeet Singh Ganda. These collaborations have further enhanced the impact of his work in the development of innovative therapeutic solutions.
Conclusion
Yong Quan's contributions to the field of antibody formulations demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly improve treatment options for patients with serious disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile